Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-01

Clinical Trial Update: Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on acute normovolemic hemodilution in patients with ovarian cancer undergoing cytoreductive surgery; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Ovarian Cancer, Fallopian Tube Carcinoma | Phase 2 | Status: RECRUITING